Cleveland Jewish News: William Schiemann, associate professor of general medical sciences, led a team of researchers who found a link between a micro ribonucleic acid molecule and late-stage breast cancer. “Our micro RNA inactivates [a protein called] Bim, and we think this leads to chemo resistance to these metastatic cancers,” Schiemann said. Lower Bim levels, coupled with higher miR-181a levels, allow the spread of cancer.
Medicine’s William Schiemann and researchers target molecule’s role in late-stage breast cancer
- Law’s Jonathan Adler examines the legal and policy issues of legalizing marijuana
- Environmental health sciences’ Karen Mulloy discusses Yale fracking study
- CWRU psychologist offers tips for a better night’s sleep
- Tapingo now available at new campus locations
- Study finds women seek anti-aging clinicians to receive more personalized care, “natural” treatments for menopausal symptoms